Subsequently, we constructed a nomogram using WHO grade, chromosome 1p/19q codeletion, primary therapy outcome, IDH status, and TPM4 levels to predict 1-year OS, 2-year OS, and 3-year OS in patients with glioma (Fig. 6A). Here, TPM4 is linked to central nervous system cancer.